Michael Jablonover, MD, MBA, FACP

‚Äč

Earlier this year, Michael R. Jablonover, MD, MBA, FACP, was appointed senior vice president and chief medical officer (CMO) of UMMC’s University campus. As the CMO, he oversees patient safety, health care quality improvement, clinical effectiveness and the training of residents and fellows – physicians who have graduated from medical school and are seeking advanced training in specialties and subspecialties.

Before being appointed CMO, Jablonover served for five years as chief executive officer of University of Maryland Rehabilitation & Orthopaedic Institute (UM Rehab), and held other physician leadership and administrative positions there and at the former University Specialty Hospital.

“Dr. Jablonover comes to his new post with a stellar reputation for professionalism, collaboration and teamwork,” said Jeffrey A. Rivest, president and chief executive officer of UMMC.

“While many aspects of health care are undergoing change nationally and in Maryland, the goal of the University of Maryland Medical Center has not wavered: to provide the best possible care for patients,” Jablonover said. “I look forward to working even more closely with physicians and the leadership team at UMMC to ensure that the highest standards of care are delivered efficiently and effectively.”

Jablonover is also a clinical assistant professor at the University of Maryland School of Medicine. He previously served as an assistant professor in the Department of Medicine from 1995 – 2005 and was significantly involved in UMMC’s residency training programs, hospitalist program and medical student education programs.

Jablonover is a Phi Beta Kappa graduate of Duke University. He completed his residency at UMMC – just like the residents he now oversees – and at the Baltimore VA Medical Center. He is board-certified in internal medicine and is a Fellow of the American College of Physicians.